2023 - Research.com Best Female Scientist Award
2022 - Research.com Best Female Scientist Award
Irene L. Andrulis applies her multidisciplinary studies on Cancer and Prostate in her research. She conducted interdisciplinary study in her works that combined Prostate and Cancer. She merges many fields, such as Genetics and Computational biology, in her writings. She integrates Computational biology and Gene in her studies. She integrates many fields, such as Gene and Heritability, in her works. She integrates many fields in her works, including Heritability and Genotype. Irene L. Andrulis conducted interdisciplinary study in her works that combined Genotype and Single-nucleotide polymorphism. Single-nucleotide polymorphism and Linkage disequilibrium are two areas of study in which she engages in interdisciplinary research. Her study connects Genetics and Linkage disequilibrium.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
Karoline B. Kuchenbaecker;Karoline B. Kuchenbaecker;John L. Hopper;Daniel R. Barnes;Kelly-Anne Phillips.
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
Kyriaki Michailidou;Per Hall;Anna Gonzalez-Neira;Maya Ghoussaini.
Nature Genetics (2013)
MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma
Kolja Eppert;Stephen W Scherer;Hilmi Ozcelik;Rosa Pirone.
Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction.
K. E. Noonan;C. Beck;T. A. Holzmayer;J. E. Chin.
Proceedings of the National Academy of Sciences of the United States of America (1990)
RAD51B in Familial Breast Cancer
Liisa M. Pelttari;Sofia Khan;Mikko Vuorela;Johanna I. Kiiski.
PLOS ONE (2016)
Association analysis identifies 65 new breast cancer risk loci
Kyriaki Michailidou;Kyriaki Michailidou;Sara Lindström;Sara Lindström;Joe Dennis;Jonathan Beesley.
Breast-Cancer Risk in Families with Mutations in PALB2
A. C. Antoniou;S. Casadei;T. Heikkinen;D. Barrowdale.
The New England Journal of Medicine (2014)
HER2 and responsiveness of breast cancer to adjuvant chemotherapy.
Kathleen I. Pritchard;Lois E. Shepherd;Frances P. O'Malley;Irene L. Andrulis.
The New England Journal of Medicine (2006)
MicroRNA related polymorphisms and breast cancer risk
Sofia Khan;Dario Greco;Dario Greco;Kyriaki Michailidou;Roger L. Milne;Roger L. Milne.
PLOS ONE (2014)
Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).
Nasim Mavaddat;Daniel Barrowdale;Irene L. Andrulis;Susan M. Domchek.
Cancer Epidemiology, Biomarkers & Prevention (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: